Trwa ładowanie...
d19cexn
espi

SOPHARMA AD - Current report 4 buy back 06012012 (4/2012)

SOPHARMA AD - Current report 4 buy back 06012012 (4/2012)

Share
d19cexn

| | POLISH FINANCIAL SUPERVISION AUTHORITY | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | UNI - EN REPORT No | 4 | / | 2012 | | | | |
| | Date of issue: | 2012-01-06 | | | | | | | | | |
| | Short name of the issuer | | | | | | | | | | |
| | SOPHARMA AD | | | | | | | | | | |
| | Subject | | | | | | | | | | |
| | Current report 4 buy back 06012012 | | | | | | | | | | |
| | Official market - legal basis | | | | | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | | | | | | | | | | |
| | Unofficial market - legal basis | | | | | | | | | | |
| | Contents of the report: | | | | | | | | | | |
| | ACQUISITION OF OWN SHARES Current report No. 4/2012 Dated 06 January 2012 The Board of Directors of SOPHARMA AD (the ?Company") hereby informs that from January 03 2012 up to and including January 06 2012 the Company bought 459 own shares representing 0.00035% of the share capital of the Company, to the total value of BGN 1460 on the Bulgarian Stock Exchange. The average price per share was BGN 3.175. The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010. The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers. The total number of own shares after these transactions is 2518509, representing 1.908% of the share capital of the Company. Legal grounds: Art. 56.1 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organized Trading, and Public Companies dated 29 July 2005. Signatures of individuals authorized to represent
the Company Ognian Donev | | | | | | | | | | |
| | Annexes | | | | | | | | | | |
| | File | Description | | | | | | | | | |
| | Current report 4 buy back 06012012.doc | Current report 4 buy back 06012012 | | | | | | | | | |

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

| | | SOPHARMA AD | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | SOPHARMA AD | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 1220 | | Sofia | | | |
| | | (post code) | | (city) | | | |
| | | IlienskoShosse | | 16 | | | |
| | | (street) | | (number) | | | |
| | | +359 2 813 42 00 | | +359 2 936 02 86 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nd | | | | | |
| | | (NIP)
| | | (REGON) | | |

d19cexn

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-01-06 Ognian Donev Executive Director

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

d19cexn

Podziel się opinią

Share
d19cexn
d19cexn